Revive Therapeutics Ltd (RVVTF) Stock Price & News

All values in CAD	2025 оны 6-р сар	2025 оны 9-р сар	2025 оны 12-р сар	2026 оны 3-р сар
Revenue	-	-	-	-
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	336.32 мян	200.14 мян	283.25 мян	242.05 мян
Operating expense	336.39 мян	220.13 мян	283.30 мян	463.87 мян
Total operating expenses	336.39 мян	220.13 мян	283.30 мян	463.87 мян
Operating income	-336.39 мян	-220.13 мян	-283.30 мян	-463.87 мян
Other non operating income	73.85 мян	-	-	-
EBT including unusual items	-9.60 сая	-281.75 мян	-238.72 мян	-506.50 мян
EBT excluding unusual items	-143.94 мян	-281.75 мян	-234.70 мян	-506.50 мян
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-9.60 сая	-281.75 мян	-238.72 мян	-506.50 мян
Net profit margin	-	-	-	-
Earnings per share	-	-	-	-
Interest and investment income	-	277.00	-	-
Interest expense	-	-	-	-
Net interest expenses	-	277.00	-	-
Depreciation and amortization charges	62.00	46.00	48.00	47.00
EBITDA	-336.32 мян	-220.08 мян	-283.25 мян	-463.82 мян
Gain or loss from assets sale	-	-	-	-

Ask anything